Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance

Gynecological Endocrinology

Volumn 14, Issue 5, 2000, Pages 327-336

  Fedorcsak, P ^b   Storeng, R ^a   Dale, P O ^b   Tanbo, T ^b   Abyholm, T ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b Univ Oslo ^*

Author keywords

Granulosa cell; Insulin resistance; Lactate; Polycystic ovary syndrome; Progesterone

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; INSULIN; INSULIN RECEPTOR; LACTIC ACID; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FEMALE INFERTILITY; GRANULOSA CELL; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUTEAL CELL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0033694950     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167701     Document Type: Article

References (37)

1. Polycystic ovary syndrome
2. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome
3. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: Evidence of two distinct populations
4. Inhibitory effect of sandostatin on secretion on luteinising hormone and ovarian steroids in polycystic ovary syndrome
5. Insulin sensitivity in women with polycystic ovary syndrome: Relationship to hyperandrogenemia
6. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome
7. Metabolic regulation of androgen production by human thecal cells in vitro
8. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
9. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states
10. Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary
11. Mechanisms subserving the trophic actions of insulin on ovarian cells. In vitro studies using swine granulosa cells
12. Insulin regulates low density lipoprotein metabolism by swine granulosa cells
13. Effect of gonadotropins, insulin and IGF-I on granulosa luteal cells from polycystic ovaries
14. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries
15. Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosa-luteal cells: Effects of octreotide and insulin
16. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
17. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome
18. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
19. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone
20. Continuous infusion of glucose with model assessment: Measurements of insulin resistance and beta-cell function in man
21. Polycystic ovary syndrome: Low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients
22. Isolation of LH, FSH and TSH from human pituitaries after removal of HGH
23. Stimulation of progesterone synthesis in luteinized human granulosa cells by human chorionic gonadotropin and 8-bromo-adenosine 3',5'-monophosphate: The effect of low density lipoprotein
24. Cultured human granulosa cells as a model for corpus luteum function: Relative roles of gonadotrophin and low density lipoprotein studied under defined culture conditions
25. A sensitive protein assay methods using micro-titer plates
26. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome
27. Gonadotropin and ovarian steroid production in polycystic ovarian syndrome during suppression with gonadotropin-releasing hormone agonist
28. Gonadotrophic control of human granulosa cell glycolysis
29. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: A comparison between normal and polycystic ovaries
30. Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartments of polycystic ovaries
31. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome
32. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome
33. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist
34. In-vitro progesterone production of human granulosa-luteal cells: The impact of different stimulation protocols, poor ovarian response and polycystic ovarian syndrome
35. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with ovarian disease
36. The effect of insulin on in vitro progesterone production of human granulosa cells
37. Follicular fluid lipoproteins in preovulatory period and their relationship with follicular maturation and progesterone production by human granulosa-luteal cells in vivo and in vitro